Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Current Parent Company Summary

Current Parent Company Name: Novo Holdings A/S
Ownership Structure: privately held
Headquartered in: Denmark
Major Industry: pharmaceuticals
Specific Industry: pharmaceuticals
Penalty total since 2000$110,887,792
Number of records: 14
Top 5 Offense Groups (Groups Defined)Penalty TotalNumber of Records
government-contracting-related offenses$66,675,0004
healthcare-related offenses$26,100,0003
competition-related offenses$18,030,1492
environment-related offenses$77,0334
safety-related offenses$5,6101
Top 5 Primary Offense TypesPenalty TotalNumber of Records
False Claims Act and related$66,675,0004
off-label or unapproved promotion of medical products$26,100,0003
Foreign Corrupt Practices Act$9,030,1491
kickbacks and bribery$9,000,0001
environmental violation$77,0334
Notes: Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.

Links: Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.

Individual Penalty Records:

Click on the company or penalty amount for more information on each case.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)
CompanyPrimary Offense TypeYearAgencyPenalty Amount sort icon .
Novo Nordisk Inc.False Claims Act and related2017DOJ_CIVIL$58,650,000
Novo Nordisk Inc.off-label or unapproved promotion of medical products2011FDA$25,000,000
Novo Nordisk A/SForeign Corrupt Practices Act2009SEC$9,030,149
Novo Nordisk A/Skickbacks and bribery2009DOJ_CRIMINAL$9,000,000
Novo Nordisk IncFalse Claims Act and related2022USAO$6,300,000
Novo Nordisk Inc.off-label or unapproved promotion of medical products2011MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,574,209
Novo Nordisk Inc.False Claims Act and related2017MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,320,963
Novo Nordisk Inc.False Claims Act and related2011USAO$1,725,000
Novo Nordisk Inc.off-label or unapproved promotion of medical products2017CA-INS$1,100,000
Novo Nordisk Pharmaceutical Industries, Inc.environmental violation2009NC-ENV$36,836
NOVOZYMES BIOLOGICALS, INCenvironmental violation2009EPA$26,797
NOVOZYMES BIOLOGICALS, INC.environmental violation2016EPA$8,400
NOVOZYMES BIOLOGICALS, INC.workplace safety or health violation2003OSHA$5,610
NOVO NORDISK BIOCHEM, N.A., INC.environmental violation2000EPA$5,000
(*): Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting.